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ABSTRACT  
Introductions: Ureteral stones account for 20% urinary stone. Two third of 
ureteral stones are seen in lower third of ureter. Medical expulsive therapy is 
effective for such stones. This study was designed to observe the efficacy of 
‘tamsulosin’ a selective alpha-1 adrenoreceptor antagonist in the management 
of lower ureteric stone. 
Methods: A cross sectional study of 70 cases of distal ureteral stones of sizes 5 
to 10 mm was taken in the Department of Surgery of Shree Birendra Hospital, 
Nepalese Army Institute of Health Sciences (NAIHS) from January 2011 to 
2013. Patients were randomly divided into tamsulosin and analgesic only 
groups. Stone expulsion at the end of three weeks was confirmed by X-ray or 
Ultrasonography.
Results: Out of 70 patients, stone clearance rate in tamsulosin group was 28 
in 35 cases (80%) and 21 in 35 cases (60%) in group II with analgesic only. The 
mean time of stone expulsion was 8.3 days in group I and 13.5 days in group II.
Conclusions: In this study the use of tamsulosin in treatment of lower ureteral 
stones less than 10 mm was safe and effective.
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Plain Language Summary 
The study was conducted to see effectiveness of tamsulosin in management of 
lower ureteric stone. The mean time of stone expulsion was lesser in tamsulosin 
group. tamsulosin is an effective treatment.
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INTRODUCTIONS
Urinary stone is a common urological problem 
throughout the world.1 More than 50% of lower 
ureteric stones less than 5 mm pass out spontaneously. 
This decreases to less than 15% for larger stones more 
than 5 mm.2
Studies have shown that, ‘tamsulosin’ a selective 
alpha-1 adrenoreceptor antagonist, is effective in 
expulsion of lower ureteral calculi. In this study, we 
observed the efficacy of tamsulosin in selected patients 
with lower ureteral stone.
METHODS
This was a cross sectional study conducted on 
outpatient basis from January 2011 to January 2013 
at Shree Birendra Hospital, National Army Institute 
of Health Sciences, Kathmandu, Nepal. Patients 
older than 15 years of age who visited surgery OPD 
(outpatient department) and emergency department 
with symptomatic, unilateral, solitary lower ureteral 
stones (located below sacroiliac joint) of 5 to 10 mm 
size were included. Plain X-ray or ultrasound of the 
KUB (Kidney-Ureter-Bladder) were used to detect the 
stones. Those with urinary tract infection, renal failure, 
history of urinary surgery or endoscopic treatment, 
uncorrected distal obstruction and moderate to severe 
hydronephrosis were excluded from the study. Patients 
who developed deranged renal function or intractable 
pain that could not be managed on OPD basis or 
refused to participate in the study were also excluded. 
Complete haemogram, blood urea, serum creatinine, 
urine for routine examination and culture sensitivity, 
X-ray and ultrasound KUB were carried out in all 
patients. Written consent from patients or guardian or 
family was obtained. Permission from hospital authority 
was taken for the study.
Patients were divided randomly by envelop methods 
for tamsulosin 0.4 mg at bed time (study, group I) and 
observation with analgesic only (control, group II). 
Patients were further grouped as per stone size less 
than 5mm, size 5.1mm-7mm, and 7.1mm-10mm). All 
patients were advised to have high fluid intake more 
than three liters a day. Tablet Diclofenac 50 mg three 
times a day for five days and thereafter on demand 
was given for pain management. The patients were 
followed weekly for three weeks in surgery outpatient 
department. They were evaluated with urine routine 
examination, serum creatinine and ultrasound or X-ray 
KUB were performed to observe complication and 
passes of stone.
Successful results were defined as complete stone 
clearance. The time of stone expulsion was based on 
patient’s notice of passing stone during urination and or 
confirmation during weekly follow up. The failure was 
considered if stone persisted at the end of 3rd week (21 
days). Patients who required admission for uncontrolled 
pain or complication or discontinued the study were 
also considered as failure. Those with persisting stone 
after 21 days were considered for endoscopic removal.
RESULTS
There were total 70 patients (35 in each group I and 
II). There were 41 (58.5%) male patient and 29 (41.4%) 
female patient. Age ranged from 15 years to 63 years. 
The smallest size of stone was 4.6 mm and the largest 
10.5 mm.  Stone clearance was 28 out of 35 cases (80%) 
in Group I and 21 out of 35 cases (60%)  in group II. 
Table 1. Size of distal ureteral stone and clearance
Size of stone
Tamsulosin group I (28 
stone clearance out of 
35)
Control group II (22 
stone clearance out 35)
< 5mm 100% (13/13) 93% (15/16)
5.1 mm -7mm 73.33% (11/15) 36.36% (4/11)
7.1 mm -10mm 57% (4/7) 25% (2/8)
DISCUSSIONS
Various treatment options are available for the 
management of distal ureteral calculi.Advances in 
endourological techniques and instrumentation have 
changed the management of ureteral stones by open 
surgeries to either minimal invasive methods like ESWL 
and ureterorenscopic removal of stones or simple 
watchful waiting. The minimal invasive therapies for 
ureteral stone are now the accepted gold standards. 
Nevertheless, these techniques are not risk-free, quite 
expensive and are not widely available in the developing 
countries.3
Watchful waiting is appropriate for small stones that are 
not causing acute symptoms and that are likely to pass 
out spontaneously.4 The choice of the ideal method of 
treatment depend on the stones size, location, number, 
spasm of muscle, mucosal oedema, inflammation, 
ureteral anatomy,type of equipment available, needs of 
the patient and the skills of the surgeon.5 The problem 
that can emerge during expectant treatment may 
include development of hydronephrosis, deranged 
renal function, infection or urosepsis and colicky pain.6
Whenever we consider for conservative treatment, 
numerous studies currently demonstrate promising 
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result for adjuvant medical expulsion therapy (MET) 
in term of rapid stone expulsion and symptom free 
period. The drugs commonly used for MET are calcium 
channel blockers, corticosteroids, prostaglandin 
synthesis inhibitors and alpha- blockers.7Borghi and 
colleagues8used an expulsive therapy consisting of 
methyl prednisolone and nifedipine in randomized 
double blind study, treating patients with distal 
ureteral stones of different size. They demonstrated 
beneficial effect in reducing the time to stone passage 
and improving the expulsion rate. Their results were 
confirmed by Porpiglia et al, who used nifedipine and 
deflazacort.9 Cooper and associates treated 70 patients 
having ureteral calculi and found that addition of 
nifedipine, prednisone, acetaminophen and antibiotics 
to standard medical therapy resulted in higher stone 
passage rate and fewer workday, emergency visits 
and surgical interventions.10 But these studiesfailed 
to quantify the result of each drug. These drugs also 
have many adverse effects like asthenia, headache, 
palpitations which may result in discontinuation of 
treatment. Due to the more adverse effect of other 
drugs, the use of alpha-blockers has increased recently, 
in which it was observed that tamsulosin is a safe and 
effective drug that enhances spontaneous passage of 
distal ureteral stones sized less than 10 mm.
The human ureter contains predominantly alpha 
receptors which are further classified as alpha 1 and 
alpha 2 receptors. In turn alpha 1 receptors which are 
divided into subtypes on the basis of their selectivity. 
Alpha 1a (proximal urethra, prostate, bladder outlet), 
alpha1b (smooth muscles of vessels) and alpha1d 
(detrusor, lower ureter).11 When stimulated, they 
inhibit the basal tone, peristaltic wave frequency and 
the ureteral contractions even in the intramural part of 
lower ureter. They may work on the obstructed ureter 
by inducing an increase in the intraureteral pressure 
gradient around the stone, which increase in the urine 
bolus above the stone as well as decreased peristalsis 
below the ureter, in association with the decrease in 
basal and micturition pressures even at the bladder 
neck, thereby an increased chance of stone expulsion.12 
Ukhal and co-workers were the first to report positive 
result in accelerating the lower ureteral stone passage 
using alpha blocker agent.13
In our study the overall stone clearance rate was 80% 
in case of tamsulosin group whereas 60% in control 
group. De Sio et al published a study of 96 patients and 
achieved 90% expulsion rate with tamsulosin therapy.14 
MS Griwan et al, noticed overall stone expulsion rate of 
21 out of 30 patients (70%) was observed for control 
group and 27 out of 30 patients (90%)in study group.15
Cervenakov et al, concluded that the treatment by 
α1 blockers considerably decreased not only lower 
urinary tract symptoms (LUTS) but also helped to 
accelerate the passing of minor calculi from the terminal 
parts of the ureter of 80.4% of patients.11Dellabella et al, 
used tamsulosin as a spasmolytic drug during episodes 
of ureteral colic due to juxtavesical calculi, observed an 
increased stone expulsion rate and with a decrease in 
stone expulsion time, the need for hospitalization and 
endoscopic procedures.16
Regarding the size of stone and clearance rate in this 
study, there was 100% clearance in case of group I and 
93% clearance in group II when stone size was less 
than 5mm. In cases of stone size 5.1 mm- 7mm, the 
clearance rate was 73.33% in group I and 36.36% in 
group II. When stone size was in the range of 7.1 mm 
-10mm the clearance rate was 57.14% in group I and 
25% in group II. The mean time of stone expulsion was 
8.3 days in group I and 13.5 days in group II.
Jamshed Rahim et al, has been published an article 
where the average expulsion time of stone in 
tamsulosin group was 13.30±6.31 days and in control 
group it was 19.18±4.66 days. In tamsulosin group the 
total number of stone expulsion was in 37( 87.22%) 
out of 45 patients and in control group stone expulsion 
was in 22 (48.88%) out of 45 patients only. Treatment 
with MET showing a significant results in term of stone 
clearance as compared to treatment with control group 
i.e., p-value=0.001.17 Abdulla- al Ansari et al, reported 
100 cases of distal ureteric stones  where the stone 
expulsion occurred in 41 of 50 patients (82%) in group 
with MET and in 28 of 46 patients (61%) in  placebo 
group  (p = .02). The expulsion time was significantly 
shorter in the tamsulosin group 6.4 ± 2.77 days vs. 9.87 
± 5.4 days for groups 1 and 2 respectively.18 Sayed MA et 
al, reported another study where the stone expulsion 
rate was 51.1% for Group A (control group), compared 
to 88.9% for Group B (study group) (p=0.001). The 
average time to expulsion was 12.53+/-2.12 days for 
Group A and 7.32+/-0.78 days for Group B (p=0.04).19
The overall stone clearance in two groups showed 
variable result in different size of stones, however the 
expulsion rate was better in MET group than control 
group and time of expulsion also was significantly 
different especially when size of stone was more than 
5 mm.
CONCLUSIONS
In our study, tamsulosin was more effective in distal 
ureteral stone clearance than analgesic alone, decrease 
acute attacks by acting as a spasmolytic. Appropriately 
used, it may have substantial financial benefits by 
reducing the number of interventional procedures and 
the acute attacks. 
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